Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Liver Dysfunction
Interventions
PROCEDURE

liver biopsy

5 mm fragment of liver transplant biopsy taken for clinical indication

Trial Locations (15)

21201

COMPLETED

University of Maryland School of Medicine, Baltimore

23298

COMPLETED

Transplant Surgery, VCU Medical Center, Richmond

37232

WITHDRAWN

Vanderbilt University Medical Center, Vanderbilt Transplant Center, Nashville

48202

RECRUITING

Henry Ford Transplant Institute, Detroit

60611

COMPLETED

Northwestern Memorial Hospital, Chicago

75246

COMPLETED

Baylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute, Dallas

94143

COMPLETED

University of California San Francisco, Transplant Research Unit, San Francisco

98195

COMPLETED

Division of Transplant Surgery, University of Washington, Seattle

NSW 2050

COMPLETED

Centenary Institute of Cancer Medicine & Cell Biology, Royal Prince Alfred Hospital, Camperdown

T6G 2R7

COMPLETED

University of Alberta, Laboratory Medicine and Pathology, Edmonton

40-027

COMPLETED

Dep. of Nephrology, Transplantation & Internal Med., Samodzielny Publiczny Szpital Kliniczny im. A. Mieleckiego, Katowice

71-455

COMPLETED

Independent Public Composite Regional Hospital, Szczecin

02-005

COMPLETED

Warsaw Medical University, Jesus the Child Clinical Hospital, Warsaw

02-097

COMPLETED

Warsaw Medical University, Independent Public Clinical Hospital, Warsaw

SE5 9NU

COMPLETED

Institute for Liver Science, King's College London, London

All Listed Sponsors
lead

University of Alberta

OTHER